Maybe it has been written somewhere above, but I understand the basis of everything after the split should be equal to Pfizer's basis before the split.But, the cash you get in lieu of the partial Viatris share, is it part of the basis of Viatris?
Rick Milton said:
Some had posted a screen shot of the Corporate Securities Spinoff Screen in which he had posted all the information was filled in. It worked perfectly and I went back on here to THANK HIM so much, but could not find the post. I wish that would happen more often -- I don't know if it was taken down or removed, but it was very helpful! I can try to summarize here - go to Corporate Security Spinoff. Security Name is Pfizer, New Company is Viatris, New Shares issued: .12408; Cost per old share: 36.04; Cost per new share: 16.34. You can memo it as Pfizer spin-off to Viatris and the Transaction Date is 11/17/2020. I hope that helps someone else! Sorry I can't provide the screen shot!
Does anyone know the last QW revision that used the remove/add method for Cost Basis calculations?
...@Tom Young... When Quicken performed the spinoff, it first removed all the Pfizer shares ( but not the costs associated with it) and then made 2 entries for each lot. But it was not the RtrnCap, miscinc entry. Just an ad shares for Pfizer and an ad shares for Viatris using around 95%/5% split ratio. The result of this added to my cost basis by $5585.47. When I look at my portfolio view ... my original cost basis before the spinoff was $5899.30 and after the spinoff was $11484.77. It should be $5585.47 which is the total I get from the spinoff. Why it added these 2 together I don't know.
Splasher,Did QW R28.28 use the remove/add method or the new Return of Capital method? Thanks.
@q-lurker... thank you for the help...in my portfolio view and holdings view, this is what I see. see screen shot. The amount invested was $5899.30.
@Rick8 The older method had some issues with the Average Annual Return calculation, but I think those could have been resolved with a less dramatic change.